Nicholas Naclerio bought stock once, on Apr 20, 2026
Director at Alamar Biosciences, Inc., and 1 other company
SEC CIK 0001534166 · Filings on SEC.gov ↗
Nicholas Naclerio's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Companies
Every filing
2 filings since Mar 2016, newest first
About Nicholas Naclerio
Nicholas Naclerio, Ph.D. (born circa 1962) is an accomplished biotechnology executive and venture capitalist serving as an Independent Director on the board of Alamar Biosciences, Inc. (ALMR) since April 30, 2020.( He recently filed as a director and insider on April 16, 2026, ahead of the company's NASDAQ listing.(
Naclerio is the Founding Partner of Illumina Ventures, where he focuses on building companies at the technology-health intersection, with Alamar Biosciences in his portfolio.( His career highlights include SVP of Corporate & Venture Development at Illumina Inc., leading acquisitions, investments, and formations like Helix and GRAIL; founding General Manager of Illumina’s Enterprise Informatics; co-founding and chairing Quanterix; CEO of ParAllele BioScience (acquired by Affymetrix); and leading Motorola Life Sciences (acquired by GE).( He holds a B.S. in Engineering from Duke University, was a Winston Churchill Scholar at Cambridge, and earned a Ph.D. in Electrical Engineering from the University of Maryland.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.